Smoking cessation remains a challenge among PAD patients undergoing revascularization

Smoking cessation rates among patients with peripheral artery disease (PAD) undergoing lower extremity revascularization (LER) remain low and largely unchanged, according to a new analysis of Vascular Quality Initiative (VQI) data. The retrospective study, which was published in the Journal…
SVS smoking cessation initiative aligns with national cancer society effort to help efforts aimed at curbing the habit

Vascular specialists have been intensifying efforts to combat tobacco use through the Society for Vascular Surgery Patient Safety Organization (SVS PSO), which is leading a targeted campaign to help patients quit smoking and reduce their risk of vascular disease. The…
SVS set to take part in ACC smoking cessation webinar

The Society for Vascular Surgery (SVS) will take part in an upcoming webinar titled “Breaking the Habit, Saving Lives: The National Quality Initiative Push for Smoking Cessation” at the 2025 American College of Cardiology Quality Summit, Tuesday, Oct. 14. The…
Updated intermittent claudication guidelines reflect a decade of new evidence

The Society for Vascular Surgery (SVS) recently published comprehensive update to its clinical practice guidelines (CPGs) for the management of intermittent claudication (IC), urging clinicians to prioritize conservative treatment strategies and patient-centered care. The new recommendations, which appeared in the…
Pharmacologic treatment, follow-up in cessation services help drive abstinence in PAD patients

A recent French study suggests smoking cessation in patients with peripheral arterial disease (PAD) is achievable with intensive and appropriate management, with the prescription of a pharmacologic smoking cessation treatment and follow-up with smoking cessation services both identified as important…
VQI to host webinar on updated smoking cessation variables

The Society for Vascular Surgery (SVS) Patient Safety Organization (SVS PSO) will host a webinar on Tuesday, July 15, at 1 p.m. Eastern Time to present updates to the National Quality Initiative Smoking Cessation variables within the SVS Vascular Quality…
Smoking cessation remains a ‘ripe target’ for improved medication adherence in carotid disease

New data presented at the 2024 Vascular Annual Meeting (VAM) held June 19–22 in Chicago have revealed poor overall rates of medical therapy adherence in moderate asymptomatic carotid stenosis patients—with smoking cessation representing a “ripe target” for improvement moving forward.…

